Method for lowering blood glucose level by the administration of bioflavonoid
US6096364A · kind A · utility
256Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 22, 1998 |
| Grant date | Aug 1, 2000 |
| Priority date | — |
| Expiry date | Oct 22, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for lowering the blood glucose level in a mammal comprises administering an effective amount of a hesperetin or naringenin bioflavonoid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.